Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Newly-Hatched Great Horned Owlets Are Live on Camera at the Lady Bird Johnson Wildflower Center
-
Bitcoin and Ethereum on the Road to Recovery, While Furrever Token (FURR) Emerges as New Crypto Darling with Impressive ROI Opportunities
-
New Solana Meme Coin to Buy Now for Massive Gains
-
Solana's Next Big Meme Coin ‘HUMP’ to Hit Top Centralised Exchanges
-
RECOVERY CENTERS OF AMERICA, LAW FIRM OBERMAYER REBMANN MAXWELL & HIPPEL, AND THE HYER CALLING FOUNDATION ANNOUNCE INAUGURAL EVENT ADVOCATING FOR LEGAL RECOVERY COMMUNITY
-
BlockDAG Network Unveils Major Ecosystem Enhancements Ahead of Bitcoin Halving Event
-
RECOVERY CENTERS OF AMERICA, LAW FIRM OBERMAYER REBMANN MAXWELL & HIPPEL, AND THE HYER CALLING FOUNDATION ANNOUNCE INAUGURAL EVENT ADVOCATING FOR LEGAL RECOVERY COMMUNITY
-
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in SSR Mining Inc. with Losses of $100,000 to Contact the Firm
-
Dickey’s Barbecue to Expand Partnership with Sam’s Club
-
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Innoviz Technologies Ltd. with Losses of $100,000 to Contact the Firm
-
Sciens Building Solutions Acquires Massachusetts Company
-
Melco Resorts Finance Announces Pricing of Senior Notes Offering
-
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm
-
Voltalia consensus as of April 9th, 2024
-
EMGS: Vessel activity and multi-client sales update for the first quarter 2024
-
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet
-
EUROAPI streamlines its Executive Committee to improve focus and efficiency
-
SBA Recognizes 2024 Phoenix Award Winners of the Year for Outstanding Disaster Recovery Efforts
-
Beamr to enable real-time video streaming over 5G with NVIDIA Holoscan for Media
-
Current constipation medications don't provide relief for some patients with Chronic Idiopathic Constipation, per Gastroenterologist survey
-
Current constipation medications don't provide relief for some patients with Chronic Idiopathic Constipation, per Gastroenterologist survey
-
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in iRobot Corporation with Losses of $100,000 to Contact the Firm
-
Medicenna Presents Updated Preclinical Data on MDNA113, a First-in-Class, Targeted and Masked Bi-functional anti-PD1-IL2 Superkine, at the 2024 Annual Meeting of the American Association for Cancer Re
-
Imugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024
-
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
-
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
-
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
-
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients
-
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm
-
Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024
-
COMBINED SHAREHOLDERS’ MEETING
-
Hermès International: Shares and voting rights as of 31 March 2024
-
Total number of shares and voting rights at March 31, 2024
-
Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen
-
BraunAbility Chrysler ADA Infloor with Simple Stow™: Redefining Accessibility
-
Shopping centres controlled by Akropolis Group had over 44 million visitors last year, the tenants’ turnover reached almost EUR 1.2 billion, over 100 new and revamped shops opened, leading to growt
-
CV Holdings, Inc. Update and Financial Statements for Year Ended December 31, 2023
-
OROCO ISSUES INCENTIVE OPTIONS
-
Alliance Trust PLC - Net Asset Value
-
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
-
VINCI’s Shareholders’ General Meeting of 9 April 2024
-
Disclosure of trading in own shares from March 28th to April 5th, 2024
-
Disclosure of trading in own shares under a share buyback programme (2 April 2024)
-
Technip Energies Announces Publication Date for First Quarter of 2024 Financial Results and Conference Call
-
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
-
COFACE SA: Combined Shareholders’ Meeting on Thursday 16 May 2024 at 02.00pm
-
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Nextdoor Holdings, Inc. with Losses to Contact the Firm
-
Wawanesa Insurance Announces Wildfire Prevention Grant Recipients
-
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Lantronix, Inc. with Losses to Contact the Firm
-
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting

